AMY plaques in familial AD: Comparison with sporadic Alzheimer's disease

Neurology

Volumn 54, Issue 1, 2000, Pages 100-104

  Lippa, Carol F ^a   Schmidt, M L ^b   Nee, L E ^c   Bird, T ^d   Nochlin, D ^e   Hulette, C ^f   Mori, H ^g   Lee, V M Y ^b   Trojanowski, J Q ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

AD; AMY; Amyloid precursor protein; Confocal laser scanning microscopy; Familial AD; Presenilin

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 2;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; BRAIN DEGENERATION; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DEMENTIA; FAMILIAL DISEASE; GENE MUTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENILE PLAQUE;

EID: 0033960164     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.1.100     Document Type: Article

References (35)

1. Selkoe DJ. Cell biology of the amyloid-β protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol 1994;10:373-403.
2. Schmidt ML, Lee VM-Y, Forman M, Chiu T-S, Trojanowski JQ. Monoclonal antibodies to a 100-kd protein reveal abundant Aβ-negative plaques throughout the gray matter of Alzheimer's disease brains. Am J Path 1997;151:69-80.
3. McGeer PL, Kawamata T, McGeer EG. Localization and possible functions of presenilins in brain. Reviews in Neurosciences 1998;9:1-15.
4. Selkoe DJ. Alzheimer's disease: genotypes, phenotype, and treatments. Science 1997;275:630-631.
5. Suzuki N, Cheung TT, Cai X-D, et al. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 1994;264:1336-1340.
6. 1-40) in familial Alzheimer's disease brain. J Biol Chem 1994;269:32721-32724.
7. Scheuner D, Bird T, Citron M, et al. Fibroblasts from carriers of familial AD linked to chromosome 14 show increased Aβ production. Soc Neurosci Abstr 1995;21:1500.
8. Song X-H, Suzuki N, Bird T, et al. Plasma amyloid β protein (Aβ) ending at Aβ42(43) is increased in carriers of familial AD (FAD) linked to chromosome 14. Soc Neurosci Abstr 1995;2: 1501.
9. Scheuner D, Eckman C, Jensen M, et al. Secreted amyloid β-protein similar to that in senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 1996;2:864-870.
10. Ishii K, Ii K, Hasegawa T, Shoji S, Doi A, Mori H. Increased Aβ 42(43)-plaque deposition in early onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene. Neurosci Lett 1997;228:17-20.
11. Lemere CA, Lopera F, Kosik KS, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nature Med 1996;2:1146-1150.
12. Mann DM, Iwatsubo T, Cairns NJ, et al. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol 1996;40:149-156.
13. McKhann G, Drachman DA, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of health and human services task force on Alzheimer's disease. Neurology 1984;34:939-944.
14. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of Alzheimer disease. Neurobiol Aging 1997;18:S1-3.
15. -42 precedes other pathology in familial Alzheimer's disease. Lancet 1998;352:1-1118.
16. Nee LE, Polinsky RJ, Eldridge R, Weingartner J, Smallberg S, Ebert M. A family with histologically confirmed Alzheimer's disease. Arch Neurol 1983;40:203-208.
17. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995;16:271-284.
18. Goudsmit J, White BJ, Weitkamp LR, Keats BJB, Morrow CH, Gajdusek DC. Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin. J Neurol Sci 1981;49:79-89.
19. Struble RJ, Polinsky RJ, Hedreen JC, et al. Hippocampal lesions in dominantly inherited Alzheimer's disease. J Neuropathol Exp Neurol 1991;50:82-94.
20. Foncin JF, Salmon D, Supino-Viterbo V, et al. Demence presenile d'Alzheimer transmise dans une famille etendue. Rev Neurol (Paris) 1985;141:194-202.
21. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-1159.
22. -42 deposition in dementia with Lewy bodies: a comparison with Alzheimer's disease and aging. Arch Neurol 1999;56:1111-1118.
23. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
24. Gearing M, Mori H, Mirra SS. Aβ-peptide length and apolipoprotein E genotype in Alzheimer's disease. Ann Neurol 1996;39:395-399.
25. Lippa CF, Saunders AM, Smith TW, et al. Familial Alzheimer's disease: neuropathology cannot exclude a final common pathway. Neurology 1996;46:406-412.
26. Schmidt ML, Robinson KA, Lee VM-Y, Trojanowski JQ. Chemical and immunological analysis of heterogeneity of fibrillar amyloid in plaques of Alzheimer's disease and Down's syndrome brains revealed by confocal microscopy. Am J Pathol 1995;147:503-515.
27. DeStrooper B, Saftig P, Craessaerts K, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 1998;391:387-390.
28. Hardy J. Amyloid, the presenilins and Alzheimer's disease. TINS 1997;20:154-159.
29. Haas C, Selkoe DJ. A technical KO of amyloid-β peptide. Nature 1998;391:339-340.
30. Takashima A, Murayama M, Muramaya O, et al. Presenilin-1 associates with glycogen synthase kinase-3β and its substrate tau. Proc Natl Acad Sci USA 1998;95:9637-9641.
31. L'Hernault SW, Arduengo PM. Mutation of a putative sperm membrane protein in Caenorhabditis elegans prevents sperm differentiation, but not its associated meiotic divisions. J Cell Biol 1992;119:55-68.
32. Mann DMA, Iwatsubo T, Nochlin D, Sumi SM, Levy-Lahad E, Bird TD. Amyloid (Aβ) deposition in chromosome 1-linked Alzheimer's disease: the Volga German families. Ann Neurol 1997;41:52-57.
33. Bird TD, Sumi SM, Nemens EJ, et al. Phenotypic heterogeneity in familial Alzheimer's disease: a study of 24 kindreds. Ann Neurol 1989;25:12-25.
34. Lemere CA, Grenfell TJ, Schmidt ML, et al. Aβ and AMY antigens colocalize in the plaques of Alzheimer's disease. Soc Neurosci Abstracts 1998;1976.
35. Lemere CA, Grenfell TJ, Selkoe DJ. The "AMY" antigen co-occurs with Aβ and follows its deposition in the amyloid plaques of Alzheimer's disease and Down's syndrome. Am J Path 1999;55:29-37.